Fri Sep 06 11:58:56 UTC 2024: – The patent cliff could potentially benefit Indian pharma stocks
– Chinese diplomat praises Indian medicine for treating throat and neck pain at a low cost
– China is investigating AstraZeneca employees for potential illegal acts
– Coverage of business news and events, including the growth prospects of India and China
– Rising awareness about infertility is creating a $4.6 billion opportunity in the IVF market
– Consumer companies are expanding into the northeast of India.

Read More